Oncology Service
CD BioSciences has extensive experience in serving the oncology field. Over the years, our oncology experts have completed many oncology experiments for customers. These services have contributed to our customers' biopharmaceutical projects moving into clinical development stages, including a series of early clinical drug candidates and recent phase III clinical studies. Our comprehensive oncology drug research and development platform can provide full service from new drug target verification, in vitro biochemical screening, cell-level screening, animal pharmacodynamic evaluation, to translational medicine research.
Overall Solutions
At CD BioSciences, we firmly believe that leading science and technology is the key to drug development, for which we always keep tracking relentlessly, such as tumor metabolism, epigenetics, tumor immunology, etc. We guarantee the highest quality of our services. And we are committed to contributing to your efforts in the fight against cancer. With strong scientific expertise and extensive ready-to-use models, our oncology team supports drug discovery for novel target validation, in vitro compound profiling, in vivo PK/PD and efficacy studies and translational medicine.
- Multiple tumor cell lines.
- Multiple cell detection methods provide high-throughput and high-content screening.
- Multiple allograft tumor models.
- Various human tumor models and related genetic information.
- A variety of homologous tumor models can be used for drug screening related to tumor immunity.
- We have completed thousands of oncology drug R&D projects for world-renowned pharmaceutical companies and biological companies.
Our Features
- In vivo anti-tumor efficacy experiment (based on subcutaneous transplantation model, orthotopic tumor model and systemic tumor model)
We have mouse tumor transplantation models to test the anti-tumor activity of candidate drugs in vivo. A variety of parameters can be provided to evaluate the anti-tumor activity of candidate drugs.
- Perform pharmacokinetic studies on tumor models
In addition to conducting pharmacokinetic studies on healthy animals, we can also conduct this study on tumor-bearing mice. The result can also be instructive.
- New xenograft tumor model development
In addition to the models we have successfully established, we also provide customers with new tumor model development services.
Our Services
|
Project Name
|
Oncology Service
|
| Services |
- In vivo anti-tumor efficacy experiment (based on subcutaneous transplantation model, orthotopic tumor model and systemic tumor model)
- Perform pharmacokinetic studies on tumor models
- New xenograft tumor model establishment
|
| Cycle |
To be decided according to your needs. |
| Product Delivery Mode |
Including final product delivery, electronic data report. In addition to the agreement, relevant electronic data will be provided together, including nuclear magnetic analysis, high performance liquid chromatography, mass spectrometry, gas chromatography, etc. |
| Price |
Inquiry |
Our Advantages
- Leading technology, experienced and pioneering professional R&D team can meet the customized needs of new compounds from milligram level to kilogram level.
- High efficiency, fast response, flexible research direction, low price, short cycle and high quality.
- It has first-class production equipment and quality management system.
- Tailor customized production for customers to help customers reduce capital and time costs.
Why Choose Us?
CD BioSciences' oncology service is a customized innovative scientific research service. Each project needs to be evaluated before the corresponding analysis plan and price can be determined. If you want to know more about service prices or technical details, please feel free to contact us.
